| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 48.06 | -0.51 (-1.05%) | 41.67 - 58.18 | 2.0 million |
Market data as of 4:00PM 05/23/13. Quotes are delayed by at least 15 min.
| Open | 48.17 |
|---|---|
| Previous Close | 48.57 |
| Day's Range | 47.51 - 48.41 |
| Market Cap | 9.9B |
| Avg Volume (10 Day) | 2.0M |
| Price/Earnings (Trailing 12 Mo.) | 59.7x |
| Earnings Per Share (Trailing 12 Mo.) | 1.59 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Catamaran to Present at Bank of America Merrill Lynch 2013 Health Care Conference
PR Newswire - Monday 05/06/2013 2:30 PM ET
Catamaran Corporation Announces Strong First Quarter Financial Results
PR Newswire - Thursday 05/02/2013 6:00 AM ET
| CTRX | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 104.52% | |
| Net Income Growth (1yr) | 602.36% | |
| Total Debt/Equity | 0.23 | |
| LT Debt/Equity | 0.22 | |
| Earnings Yield | 1.68% | |
| Price/Sales | 0.87 |
| Company | Last | Change |
|---|---|---|
| Fresenius Medical Care AG & Co KGaA | 34.73 | +1.19% |
| DaVita HealthCare Partners Inc | 125.56 | -0.44% |
| MEDNAX Inc | 93.01 | +0.87% |
| HealthSouth Corp | 30.30 | +0.36% |
| Acadia Healthcare Company Inc | 32.74 | +1.68% |
Data is delayed by at least 15 min.